237 related articles for article (PubMed ID: 21984246)
1. Production of a particulate hepatitis C vaccine candidate by an engineered Lactococcus lactis strain.
Parlane NA; Grage K; Lee JW; Buddle BM; Denis M; Rehm BH
Appl Environ Microbiol; 2011 Dec; 77(24):8516-22. PubMed ID: 21984246
[TBL] [Abstract][Full Text] [Related]
2. Vaccines displaying mycobacterial proteins on biopolyester beads stimulate cellular immunity and induce protection against tuberculosis.
Parlane NA; Grage K; Mifune J; Basaraba RJ; Wedlock DN; Rehm BH; Buddle BM
Clin Vaccine Immunol; 2012 Jan; 19(1):37-44. PubMed ID: 22072720
[TBL] [Abstract][Full Text] [Related]
3. Protective T Cell and Antibody Immune Responses against Hepatitis C Virus Achieved Using a Biopolyester-Bead-Based Vaccine Delivery System.
Martínez-Donato G; Piniella B; Aguilar D; Olivera S; Pérez A; Castañedo Y; Alvarez-Lajonchere L; Dueñas-Carrera S; Lee JW; Burr N; Gonzalez-Miro M; Rehm BH
Clin Vaccine Immunol; 2016 Apr; 23(4):370-8. PubMed ID: 26888185
[TBL] [Abstract][Full Text] [Related]
4. Novel particulate vaccines utilizing polyester nanoparticles (bio-beads) for protection against Mycobacterium bovis infection - a review.
Parlane NA; Rehm BH; Wedlock DN; Buddle BM
Vet Immunol Immunopathol; 2014 Mar; 158(1-2):8-13. PubMed ID: 23707076
[TBL] [Abstract][Full Text] [Related]
5. Recombinant lactococcus lactis secreting viral protein 1 of enterovirus 71 and its immunogenicity in mice.
Xu P; Wang Y; Tao L; Wu X; Wu W
Biotechnol Lett; 2019 Jul; 41(6-7):867-872. PubMed ID: 31119429
[TBL] [Abstract][Full Text] [Related]
6. Immune Responses to Orally Administered Recombinant
Zhang F; Zhang Z; Li X; Li J; Lv J; Ma Z; Pan L
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696469
[TBL] [Abstract][Full Text] [Related]
7. Expression of hepatitis B virus surface antigen determinants in Lactococcus lactis for oral vaccination.
Zhang Q; Zhong J; Huan L
Microbiol Res; 2011 Feb; 166(2):111-20. PubMed ID: 20227266
[TBL] [Abstract][Full Text] [Related]
8. Expression of a hepatitis A virus antigen in Lactococcus lactis and Escherichia coli and evaluation of its immunogenicity.
Berlec A; Malovrh T; Zadravec P; Steyer A; Ravnikar M; Sabotič J; Poljšak-Prijatelj M; Štrukelj B
Appl Microbiol Biotechnol; 2013 May; 97(10):4333-42. PubMed ID: 23371298
[TBL] [Abstract][Full Text] [Related]
9. Immunogencity of antigens from Mycobacterium tuberculosis self-assembled as particulate vaccines.
Rubio Reyes P; Parlane NA; Wedlock DN; Rehm BH
Int J Med Microbiol; 2016 Dec; 306(8):624-632. PubMed ID: 27756533
[TBL] [Abstract][Full Text] [Related]
10. Mucosal co-immunization of mice with recombinant lactococci secreting VapA antigen and leptin elicits a protective immune response against Rhodococcus equi infection.
Cauchard S; Bermúdez-Humarán LG; Blugeon S; Laugier C; Langella P; Cauchard J
Vaccine; 2011 Dec; 30(1):95-102. PubMed ID: 22019740
[TBL] [Abstract][Full Text] [Related]
11. Intranasal immunization with recombinant Lactococcus lactis secreting murine interleukin-12 enhances antigen-specific Th1 cytokine production.
Bermúdez-Humarán LG; Langella P; Cortes-Perez NG; Gruss A; Tamez-Guerra RS; Oliveira SC; Saucedo-Cardenas O; Montes de Oca-Luna R; Le Loir Y
Infect Immun; 2003 Apr; 71(4):1887-96. PubMed ID: 12654805
[TBL] [Abstract][Full Text] [Related]
12. Development of a new DNA vaccine based on mycobacterial ESAT-6 antigen delivered by recombinant invasive Lactococcus lactis FnBPA+.
Pereira VB; Saraiva TD; Souza BM; Zurita-Turk M; Azevedo MS; De Castro CP; Mancha-Agresti P; Dos Santos JS; Santos AC; Faria AM; Leclercq S; Azevedo V; Miyoshi A
Appl Microbiol Biotechnol; 2015 Feb; 99(4):1817-26. PubMed ID: 25503506
[TBL] [Abstract][Full Text] [Related]
13. Induction of humoral and cellular immune responses against hepatitis C virus by vaccination with replicon particles derived from Sindbis-like virus XJ-160.
Zhu W; Fu J; Lu J; Deng Y; Wang H; Wei Y; Deng L; Tan W; Liang G
Arch Virol; 2013 May; 158(5):1013-9. PubMed ID: 23250650
[TBL] [Abstract][Full Text] [Related]
14. Expression of SARS-coronavirus nucleocapsid protein in Escherichia coli and Lactococcus lactis for serodiagnosis and mucosal vaccination.
Pei H; Liu J; Cheng Y; Sun C; Wang C; Lu Y; Ding J; Zhou J; Xiang H
Appl Microbiol Biotechnol; 2005 Aug; 68(2):220-7. PubMed ID: 15660214
[TBL] [Abstract][Full Text] [Related]
15. A food-grade engineered Lactococcus lactis strain delivering Helicobacter pylori Lpp20 alleviates bacterial infection in H. pylori-challenged mice.
Sun N; Zhang R; Duan G; Peng X; Wang C; Chen S; Fan Q
Biotechnol Lett; 2019 Dec; 41(12):1415-1421. PubMed ID: 31620902
[TBL] [Abstract][Full Text] [Related]
16. Production of functionalized biopolyester granules by recombinant Lactococcus lactis.
Mifune J; Grage K; Rehm BH
Appl Environ Microbiol; 2009 Jul; 75(14):4668-75. PubMed ID: 19465535
[TBL] [Abstract][Full Text] [Related]
17. Bacterial polyester inclusions engineered to display vaccine candidate antigens for use as a novel class of safe and efficient vaccine delivery agents.
Parlane NA; Wedlock DN; Buddle BM; Rehm BH
Appl Environ Microbiol; 2009 Dec; 75(24):7739-44. PubMed ID: 19837843
[TBL] [Abstract][Full Text] [Related]
18. The recombinant Lactococcus lactis oral vaccine induces protection against C. difficile spore challenge in a mouse model.
Guo S; Yan W; McDonough SP; Lin N; Wu KJ; He H; Xiang H; Yang M; Moreira MA; Chang YF
Vaccine; 2015 Mar; 33(13):1586-95. PubMed ID: 25698490
[TBL] [Abstract][Full Text] [Related]
19. Construction of recombinant Lactococcus expressing thymosin and interferon fusion protein and its application as an immune adjuvant.
Liu Z; Zhang S; Hu H; Wang H; Qiu Y; Dong M; Wang M; Cui Z; Cui H; Wang Y; He G
Microb Cell Fact; 2024 Feb; 23(1):40. PubMed ID: 38321474
[TBL] [Abstract][Full Text] [Related]
20. Oral immunization with recombinant Lactococcus lactis delivering a multi-epitope antigen CTB-UE attenuates Helicobacter pylori infection in mice.
Li X; Xing Y; Guo L; Lv X; Song H; Xi T
Pathog Dis; 2014 Oct; 72(1):78-86. PubMed ID: 24687988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
